Biocatalytic in Vitro and in Vivo FMN Prenylation and (De)carboxylase Activation
Research output: Contribution to journal › Article › peer-review
Standard Standard
In: ACS Chemical Biology, Vol. 15, No. 7, 17.07.2020, p. 1874-1882.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
APA
CBE
MLA
VancouverVancouver
Author
RIS
TY - JOUR
T1 - Biocatalytic in Vitro and in Vivo FMN Prenylation and (De)carboxylase Activation
AU - Batyrova, Khorcheska A
AU - Khusnutdinova, Anna N
AU - Wang, Po-Hsiang
AU - Di Leo, Rosa
AU - Flick, Robert
AU - Edwards, Elizabeth A
AU - Savchenko, Alexei
AU - Yakunin, Alexander F
PY - 2020/7/17
Y1 - 2020/7/17
N2 - Reversible UbiD-like (de)carboxylases represent a large family of mostly uncharacterized enzymes, which require the recently discovered prenylated FMN (prFMN) cofactor for activity. Functional characterization of novel UbiDs is hampered by a lack of robust protocols for prFMN generation and UbiD activation. Here, we report two systems for in vitro and in vivo FMN prenylation and UbiD activation under aerobic conditions. The in vitro one-pot prFMN cascade includes five enzymes: FMN prenyltransferase (UbiX), prenol kinase, polyphosphate kinase, formate dehydrogenase, and FMN reductase, which use prenol, polyphosphate, formate, ATP, NAD+, and FMN as substrates and cofactors. Under aerobic conditions, this cascade produced prFMN from FMN with over 98% conversion and activated purified ferulic acid decarboxylase Fdc1 from Aspergillus niger and protocatechuic acid decarboxylase ENC0058 from Enterobacter cloaceae. The in vivo system for FMN prenylation and UbiD activation is based on the coexpression of Fdc1 and UbiX in Escherichia coli cells under aerobic conditions in the presence of prenol. The in vitro and in vivo FMN prenylation cascades will facilitate functional characterization of novel UbiDs and their applications.
AB - Reversible UbiD-like (de)carboxylases represent a large family of mostly uncharacterized enzymes, which require the recently discovered prenylated FMN (prFMN) cofactor for activity. Functional characterization of novel UbiDs is hampered by a lack of robust protocols for prFMN generation and UbiD activation. Here, we report two systems for in vitro and in vivo FMN prenylation and UbiD activation under aerobic conditions. The in vitro one-pot prFMN cascade includes five enzymes: FMN prenyltransferase (UbiX), prenol kinase, polyphosphate kinase, formate dehydrogenase, and FMN reductase, which use prenol, polyphosphate, formate, ATP, NAD+, and FMN as substrates and cofactors. Under aerobic conditions, this cascade produced prFMN from FMN with over 98% conversion and activated purified ferulic acid decarboxylase Fdc1 from Aspergillus niger and protocatechuic acid decarboxylase ENC0058 from Enterobacter cloaceae. The in vivo system for FMN prenylation and UbiD activation is based on the coexpression of Fdc1 and UbiX in Escherichia coli cells under aerobic conditions in the presence of prenol. The in vitro and in vivo FMN prenylation cascades will facilitate functional characterization of novel UbiDs and their applications.
KW - Bacteria/enzymology
KW - Biocatalysis
KW - Carboxy-Lyases/chemistry
KW - Dimethylallyltranstransferase/chemistry
KW - Flavin Mononucleotide/chemical synthesis
KW - Oxidoreductases/chemistry
KW - Phosphotransferases (Alcohol Group Acceptor)/chemistry
KW - Prenylation
U2 - 10.1021/acschembio.0c00136
DO - 10.1021/acschembio.0c00136
M3 - Article
C2 - 32579338
VL - 15
SP - 1874
EP - 1882
JO - ACS Chemical Biology
JF - ACS Chemical Biology
SN - 1554-8929
IS - 7
ER -